| Structure of monobody 32 human MLKL pseudokinase domain complex | |
Heteromer
| 191-471 | 100 | 2×EDO; |
|
| Structure of monobody 27 human MLKL pseudokinase domain complex | |
Heteromer
| 191-470 | 100.0 | |
|
| Structure of human RIPK3-MLKL complex | |
Heteromer
Q9Y572; | 191-469 | 100.0 | 2×ZL1; |
|
| Structure of monobody 33 MLKL N-terminal domain complex | |
Heteromer
| 5-152 | 100 | 4×ZN; |
|
| Crystal structure of phosphorylated (T357/S358) human MLKL pseudokinase domain | | homo-2-mer | 191-469 | 100.0 | |
|
| Crystal Structure of the human MLKL pseudokinase domain bound to compound 2 | | monomer | 191-470 | 100.0 | 4×EDO; |
|
| Pseudokinase Domain of MLKL bound to Compound 4. | | monomer | 192-470 | 100.0 | 1×6UY; |
|
| MLKL mutant - T357AS358A | | monomer | 192-470 | 100.0 | |
|
| MLKL mutant - T357ES358D | | monomer | 192-470 | 100.0 | |
|
| Crystal structure of the human MLKL pseudokinase domain T357E/S358E mutant | | monomer | 192-470 | 100.0 | 4×GOL; |
|
| Crystal structure of the human MLKL pseudokinase domain | | monomer | 193-470 | 100.0 | 1×PXN; 1×GOL; |
|
| Crystal structure of the human MLKL kinase-like domain | | monomer | 192-469 | 100.0 | |
|
| Pseudokinase Domain of MLKL bound to Compound 1. | | monomer | 193-468 | 100.0 | 1×6UX; |
|
| Direct Activation of the Executioner Domain of MLKL by a Select Repertoire of Inositol Phosphates | | monomer | 1-156 | 100 | |
|
| Solution structure of the MLKL N-terminal domain | | monomer | 1-154 | 99.35 | |
|
| Solution structure of MLKL executioner domain in complex with a covalent inhibitor | | monomer | 2-154 | 100 | 1×QOK; |
|
| Solution structure of MLKL executioner domain in complex with a fragment | | monomer | 2-154 | 100 | 1×UJ2; |
|
| Solution structure of MLKL executioner domain in complex with a fragment | | monomer | 2-154 | 100 | 1×UJ5; |
|
| Solution structure of MLKL executioner domain in complex with a fragment | | monomer | 2-154 | 100 | 1×UJ8; |
|
| Solution structure of unliganded MLKL executioner domain | | monomer | 2-154 | 100 | |
|
| Crystal structure of MLKL executioner domain in complex with a covalent inhibitor | | monomer | 2-150 | 100.0 | 1×QOK; |
|
| Crystal structure of unliganded MLKL executioner domain | | monomer | 2-149 | 100.0 | 1×CL; |
|